Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2017 | Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIVpositive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan | Wu P.-Y.; Cheng C.-Y.; Liu C.-E.; Lee Y.-C.; Yang C.-J.; Tsai M.-.S.; Cheng S.-H.; Lin S.-P.; Lin D.-Y.; Wang N.-C.; Lee Y.-.C.; HSIN-YUN SUN ; Tang H.-J.; CHIEN-CHING HUNG | PLoS ONE | 20 | 18 | |
2020 | National surveillance of antimicrobial susceptibility of bacteremic gram-negative bacteria with emphasis on community-acquired resistant isolates: Report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) | Liu P.-Y.; Lee Y.-L.; Lu M.-C.; PEI-LAN SHAO ; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Tang H.-J.; Chen Y.-H.; WANG-HUEI SHENG ; Lee C.-M.; Liao M.-H.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 20 | 15 | |
2019 | Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018 | Lee Y.-L.; Lu M.-C.; PEI-LAN SHAO ; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG ; Lee C.-M.; Liao M.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 40 | 39 | |
2018 | Patterns of emergent resistance-associated mutations after initiation of non-nucleoside reverse-transcriptase inhibitor-containing antiretroviral regimens in taiwan: A multicenter cohort study | Cheng C.-Y.; Tsai M.-S.; Yang C.-J.; Cheng S.-H.; HSIN-YUN SUN ; Chang S.-F.; Su L.-H.; Su Y.-C.; CHIEN-CHING HUNG ; SUI-YUAN CHANG | Infection and Drug Resistance | 9 | 9 | |
2021 | Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study | Liou B.-H.; HSIN-YUN SUN ; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG ; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG ; the Taiwan HIV Study Group | Infectious Diseases and Therapy | 3 | 2 | |
2021 | Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study | Huang, Sung-Hsi; Lee, Chun-Yuan; Tsai, Chin-Shiang; Tsai, Mao-Song; Liu, Chun-Eng; Hsu, Wei-Ting; Chen, Hong-An; WANG-DA LIU ; Yang, Chia-Jui; HSIN-YUN SUN ; Ko, Wen-Chien; Lu, Po-Liang; Lee, Yuan-Ti; CHIEN-CHING HUNG ; YU-SHAN HUANG ; SUI-YUAN CHANG ; Taiwan HIV Study Group; Chen L.-Y.; Zhang J.-Y.; Chang H.-Y.; Liu W.-C.; Su Y.-C.; Wang N.-C.; Lin T.-Y.; KUAN-YIN LIN ; Yang C.-J.; Chen H.-A.; Tsai M.-S.; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; YI-CHIA HUANG ; Huang S.-H.; Lee Y.-T.; Lin J.-J.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Chen G.-J.; Lin C.-Y.; Hung T.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Tsai C.-S.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Lee C.-Y.; Chen Y.-H.; Lee C.-H.; Tsai H.-C.; Che T.-C.; Taiwan HIV Study Group | Infectious diseases and therapy | 1 | 1 | |
2009 | Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination | HSIN-YUN SUN ; Ko W.-C.; Tsai J.-J.; Lee H.-C.; Liu C.-E.; Wong W.-W.; Su S.-C.; Ho M.-W.; Cheng S.-H.; Yang C.-H.; Lin Y.-H.; Miao W.-J.; WANG-HUEI SHENG ; CHIEN-CHING HUNG | American Journal of Gastroenterology | 31 | 30 | |
2014 | Skin rash related to once-daily boosted darunavir-containing antiretroviral therapy in HIV-infected Taiwanese: incidence and associated factor | KUAN-YIN LIN ; Cheng C.-Y.; Yang C.-J.; Tsai M.-S.; SZU-MIN HSIEH ; HSIN-YUN SUN ; WANG-HUEI SHENG ; Chen M.-Y.; SUI-YUAN CHANG ; Cheng S.-H.; CHIEN-CHING HUNG | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 8 | 7 | |
2013 | Strategy to Better Select HIV-Infected Individuals for Latent TB Treatment in BCG-Vaccinated Population | Yang C.-H.; Chan P.-C.; Liao S.-T.; Cheng S.-H.; Wong W.-W.; LI-MIN HUANG ; PO-REN HSUEH ; Chiou H.-Y. | PLoS ONE | 16 | 15 | |
2022 | Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2 | Kuan-Ying A. Huang ; Zhou D.; Tan T.K.; Chen C.; Duyvesteyn H.M.E.; Zhao Y.; Ginn H.M.; Qin L.; Rijal P.; Schimanski L.; Donat R.; Harding A.; Gilbert-Jaramillo J.; James W.; Tree J.A.; Buttigieg K.; Carroll M.; Charlton S.; Lien C.-E.; Lin M.-Y.; Chen C.-P.; Cheng S.-H.; Chen X.; Lin T.-Y.; Fry E.E.; Ren J.; Ma C.; Townsend A.R.; Stuart D.I. | Theranostics | 6 | 5 | |
2022 | Targeting mechanosensitive endothelial TXNDC5 to stabilize eNOS and reduce atherosclerosis in vivo | CHIH-FAN YEH ; Cheng S.-H.; Lin Y.-S.; Shentu T.-P.; Huang R.-T.; Zhu J.; Chen Y.-T.; Kumar S.; MAO-SHIN LIN ; HSIEN-LI KAO ; Huang P.-H.; Roselló-Sastre E.; Garcia F.; Jo H.; Fang Y.; KAI-CHIEN YANG | Science Advances | 7 | 7 | |
2017 | Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up | KUAN-YIN LIN ; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG ; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | PLoS ONE | 33 | 32 | |